Table S1 from A Rationally Designed Fully Human EGFRvIII:CD3-Targeted Bispecific Antibody Redirects Human T Cells to Treat Patient-derived Intracerebral Malignant Glioma

Authors :: John H. Sampson
Darell D. Bigner
Luis Sanchez-Perez
Elizabeth A. Reap
Gary E. Archer
Stephen T. Keir
Roger E. McLendon
James E. Herndon
Patrick N. Healy
Xiuyu Cui
Scott E. Szafranski
Robert J. Schmittling
David J. Snyder
Carter M. Suryadevara
Chien-Tsun Kuan
Bryan D. Choi
Satish K. Chitneni
Teilo H. Schaller
Patrick C. Gedeon
Publication Year :: 2023
Publisher :: American Association for Cancer Research (AACR), 2023.
Abstract: Table S1 - Construct design, expression parameters and associated binding kinetic and purification yield outcomes for each of the constructs tested as part of this study.

Tools